Non-small cell lung cancer: second-line and beyond

被引：1
作者：
Stahel, R. A. [1 ]
机构：
[1] Univ Zurich Hosp, Clin & Policlin Oncol, CH-8091 Zurich, Switzerland
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
10.1093/annonc/mdl245
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：X97 / X100
页数：4
相关论文
共 36 条
[1]   Second-line treatment for advanced non-small cell lung cancer:: A systematic review [J].
Barlési, F ;
Jacot, W ;
Astoul, P ;
Pujol, JL .
LUNG CANCER, 2006, 51 (02) :159-172
[2]   Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients [J].
Cappuzzo, F ;
Varella-Garcia, M ;
Shigematsu, H ;
Domenichini, I ;
Bartolini, S ;
Ceresoli, GL ;
Rossi, E ;
Ludovini, V ;
Gregorc, V ;
Toschi, L ;
Franklin, WA ;
Crino, L ;
Gazdar, AF ;
Bunn, RA ;
Hirsch, FR .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5007-5018
[3]   Gemcitabine as second-line treatment for advanced non-small-cell lung cancer:: A phase II trial [J].
Crinò, L ;
Mosconi, AM ;
Scagliotti, G ;
Selvaggi, G ;
Novello, S ;
Rinaldi, M ;
Della Giulia, M ;
Gridelli, C ;
Rossi, A ;
Calandri, C ;
De Marinis, F ;
Noseda, M ;
Tonato, M .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2081-2085
[4]   Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial [J].
Dancey, J ;
Shepherd, FA ;
Gralla, RJ ;
Kim, YS .
LUNG CANCER, 2004, 43 (02) :183-194
[5]   Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy [J].
Esteban, E ;
de Sande, LG ;
Fernández, Y ;
Corral, N ;
Fra, J ;
Muniz, I ;
Vieitez, JM ;
Palacio, I ;
Fernández, JL ;
Estrada, E ;
Lacave, AJ .
ANNALS OF ONCOLOGY, 2003, 14 (11) :1640-1647
[6]   Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens [J].
Fossella, FV ;
DeVore, R ;
Kerr, RN ;
Crawford, J ;
Natale, RR ;
Dunphy, F ;
Kalman, L ;
Miller, V ;
Lee, JS ;
Moore, M ;
Gandara, D ;
Karp, D ;
Vokes, E ;
Kris, M ;
Kim, Y ;
Gamza, F ;
Hammershaimb, L .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (12) :2354-2362
[7]   Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer [J].
Fukuoka, M ;
Yano, S ;
Giaccone, G ;
Tamura, T ;
Nakagawa, K ;
Douillard, JY ;
Nishiwaki, Y ;
Vansteenkiste, J ;
Kudoh, S ;
Rischin, D ;
Eek, R ;
Horai, T ;
Noda, K ;
Takata, I ;
Smit, E ;
Averbuch, S ;
Macleod, A ;
Feyereislova, A ;
Dong, RP ;
Baselga, J .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2237-2246
[8]   Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine:: a multicenter randomised phase II study [J].
Georgoulias, V ;
Agelidou, A ;
Syrigos, K ;
Rapti, A ;
Agelidou, M ;
Nikolakopoulos, J ;
Polyzos, A ;
Athanasiadis, A ;
Tselepatiotis, E ;
Androulakis, N ;
Kalbakis, K ;
Samonis, G ;
Mavroudis, D .
BRITISH JOURNAL OF CANCER, 2005, 93 (07) :763-769
[9]   Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC) [J].
Gervais, R ;
Ducolone, A ;
Breton, JL ;
Braun, D ;
Lebeau, B ;
Vaylet, F ;
Debieuvre, D ;
Pujol, JL ;
Tredaniel, J ;
Clouet, P ;
Quoix, E .
ANNALS OF ONCOLOGY, 2005, 16 (01) :90-96
[10]   A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer.: The DISTAL 01 study [J].
Gridelli, C ;
Gallo, C ;
Di Maio, M ;
Barletta, E ;
Illiano, A ;
Maione, P ;
Salvagni, S ;
Piantedosi, FV ;
Palazzolo, G ;
Caffo, O ;
Ceribelli, A ;
Falcone, A ;
Mazzanti, P ;
Brancaccio, L ;
Capuano, MA ;
Isa, L ;
Barbera, S ;
Perrone, F .
BRITISH JOURNAL OF CANCER, 2004, 91 (12) :1996-2004
1234